Gilead Sciences reported $14.5B in Current Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Agios Pharmaceuticals AGIO:US $ 1702.56M 652.55M
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
ALKERMES ALKS:US 1.04B 31.75M
Alnylam Pharmaceuticals ALNY:US $ 2725.16M 255.08M
Amgen AMGN:US $ 19099M 2200M
Arena Pharmaceuticals ARNA:US $ 990.44M 131.17M
Biogen BIIB:US $ 7183.7M 464.2M
Biomarin Pharmaceutical BMRN:US $ 2357.84M 69.07M
Bluebird Bio BLUE:US $ 903.53M 194.01M
Bristol Myers Squibb BMY:US $ 29161M 2050M
Coherus Biosciences CHRS:US $ 660.01M 42.75M
Eli Lilly And LLY:US $ 17295.5M 691M
Gilead Sciences GILD:US $ 14498M 1220M
GlaxoSmithKline GSK:LN 17.57B 958M
Glaxosmithkline GSK:US $ 17566M 958M
Intercept Pharmaceuticals ICPT:US $ 493.1M 5.54M
Moderna Inc MRNA:US 10.97B 734M
Neurocrine Biosciences NBIX:US $ 1110.1M 24.7M
Novartis NOVN:VX 23.81B 1.61B
Ptc Therapeutics PTCT:US $ 1066.23M 56.13M
Puma Biotechnology PBYI:US $ 167.75M 3.99M
Regeneron Pharmaceuticals REGN:US $ 13337.6M 3282.5M
Sangamo Biosciences SGMO:US $ 554.06M 52.88M
Sarepta Therapeutics SRPT:US $ 2265.22M 6.13M
Teva Pharmaceutical Industries TEVA:US $ 12822M 421M
United Therapeutics UTHR:US $ 2317.9M 303.6M
Vertex Pharmaceuticals VRTX:US $ 8457.51M 81.79M
YTE INCY:US $ 2620.06M 170.09M